Tritonix.ai

News / Taiwan / cnyes

Handa Pharma Surges Over 6% After Patent Lawsuit Dismissed in US

Health Technology · Biotechnology · cnyes · 2026-09-02

6620

Handa Pharma's stock rallied after the original manufacturer dropped a patent infringement lawsuit against its cancer drug HND-039, with expectations of FDA approval this quarter.

What Happened

Lawsuit Resolved: Handa Pharma (6620-TW) saw a significant legal hurdle cleared as the original manufacturer, Exelisis, dropped its patent infringement lawsuit against Handa's multi-target cancer drug, HND-039. This development removes a major uncertainty regarding the product's commercialization path in the United States.

Approval Outlook: Having secured Tentative Approval (TA) in July, Handa is awaiting final FDA approval, which analysts expect to arrive this quarter. The company is preparing for a potential US market launch in the fourth quarter, either through self-distribution or strategic partnerships.

Market Performance: Shares of Handa responded positively to the news, climbing over 6.8% during intraday trading to reach a high of 93.8 TWD. The stock successfully reclaimed its annual moving average on increased trading volume, reflecting strong investor confidence.

Pipeline Expansion: Beyond HND-039, Handa is actively pursuing 505(b)(2) regulatory filings for three additional drugs, including two oncology treatments and one neurological medication. These filings are scheduled for submission over the next two years as part of the company's long-term growth strategy.

Read original

More in Health Technology

LongLife Biotech Reports 21% Revenue Growth in August, Advances CAR001 Trials

Health Technology · economic_daily · 2026-09-01

LongLife Biotech announced August revenue of NT$109 million, a 21% year-over-year increase, driven by growth in cell therapy and CDMO services.

6712

Evercyte August Revenue Hits Yearly High of NT$110 Million

Health Technology · cnyes · 2026-09-01

Taiwan-based cell therapy firm Evercyte reported an August revenue of NT$110 million, marking a year-to-date high driven by robust growth in CDMO and cell services.

6712

Yuhan Corp. Secures 131.1 Billion Won API Supply Deal with Global Pharma

Health Technology · yonhap_finance · 2026-09-01

Yuhan Corp. has signed a 131.1 billion won contract to supply active pharmaceutical ingredients to an undisclosed global pharmaceutical company through 2028.

000100

Latest in Taiwan

Taiwan Stocks Plunge 784 Points as TSMC Leads Market Decline

Electronic Technology · economic_daily · 2026-09-02

Taiwan stocks fell 784 points to close at 46,164.72 on Friday, pressured by geopolitical tensions and weakness in major tech stocks like TSMC.

2301, 2303, 2308, 2317, 2327, 2330, 2344, 2383, 2449, 2455, 3008, 3105, 3189, 3231, 3324, 3711, 4958, 5274, 6442, 6515, 8046

Hiwin Mikrosystem Sees Surge in Silicon Photonics Stage Orders Through Q2 2027

Electronic Technology · cnyes · 2026-09-02

Hiwin Mikrosystem reports a massive spike in demand for its silicon photonics inspection platforms, with order visibility extending into Q2 2027. The company is ramping up production capacity to meet the backlog and has introduced new nano-precision control solutions to capture high-end semiconductor market share.

2049, 4576

Silicon Photonics Stocks Surge: Allion and LuxNet Hit Limit Up Amid AI Demand

Electronic Technology · cnyes · 2026-09-02

Optical communication stocks Allion and LuxNet rallied to limit up as the SEMICON Taiwan exhibition and robust AI data center demand drive investor interest.

2330, 3234, 6442

Compeq's Optical Module Expansion Drives Earnings Upgrade and Price Target Hike

Electronic Technology · economic_daily · 2026-09-02

Analysts have raised Compeq's profit forecasts and price targets, citing strong growth in optical modules and satellite communications as key drivers for the company's non-consumer electronics business.

2313